Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175191 | SCV000226633 | uncertain significance | not provided | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002516665 | SCV003512676 | pathogenic | Glycogen storage disease, type V | 2024-10-15 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 675 of the PYGM protein (p.Ser675Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of glycogen storage disease (PMID: 17705025, 32735634; internal data). ClinVar contains an entry for this variant (Variation ID: 194750). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PYGM protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV002516665 | SCV003810350 | uncertain significance | Glycogen storage disease, type V | 2019-10-15 | criteria provided, single submitter | clinical testing |